Prudential Financial Inc Moderna, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 205,792 shares of MRNA stock, worth $8.18 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

205,792

Previous 211,023 2.48%

Holding current value

$8.18 Million

Previous $25.1 Million 45.12%

% of portfolio

0.02%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $332,900 - $654,607	-5,231 Reduced 2.48%	205,792 $13.8 Million
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $2.75 Million - $4.53 Million	-27,186 Reduced 11.41%	211,023 $25.1 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $315,954 - $427,243	-3,701 Reduced 1.53%	238,209 $25.4 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $3.3 Million - $4.95 Million	-47,405 Reduced 16.39%	241,910 $24.1 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $1.2 Million - $1.57 Million	-12,423 Reduced 4.12%	289,315 $29.9 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $1.29 Million - $1.74 Million	-10,863 Reduced 3.48%	301,738 $36.7 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $2.19 Million - $3.18 Million	16,154 Added 5.45%	312,601 $48 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $41.9 Million - $74.4 Million	-354,102 Reduced 54.43%	296,447 $0
Q3 2022 Nov 04, 2022	BUY	$118.07 - $194.18 $10.1 Million - $16.6 Million	85,251 Added 15.08%	650,549 $76.8 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $26.7 Million - $40.2 Million	227,585 Added 67.39%	565,298 $80.7 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $4.32 Million - $8.03 Million	34,144 Added 11.25%	337,713 $58.2 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $5.1 Million - $8.33 Million	-22,605 Reduced 6.93%	303,569 $82.9 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $35.1 Million - $76.6 Million	158,099 Added 94.06%	326,174 $135 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $16.4 Million - $29.7 Million	126,474 Added 304.02%	168,075 $39.5 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $3.33 Million - $5.67 Million	30,461 Added 273.44%	41,601 $5.45 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $25,638 - $66,245	-390 Reduced 3.38%	11,140 $1.16 Million
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $6,520 - $11,382	120 Added 1.05%	11,530 $816,000
Q2 2020 Aug 12, 2020	BUY	$29.67 - $80.0 $43,318 - $116,800	1,460 Added 14.67%	11,410 $732,000
Q1 2020 May 12, 2020	SELL	$17.78 - $31.58 $15,113 - $26,843	-850 Reduced 7.87%	9,950 $298,000
Q4 2019 Feb 11, 2020	BUY	$13.93 - $21.28 $150,444 - $229,824	10,800 New	10,800 $211,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

9.93M

Put Options Held

17.6M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Moderna, Inc. Transaction History